Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-07-01T07:07:37.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease*

Published online by Cambridge University Press:  15 May 2009

G. Rocchi ,
G. Ragona ,
C. Piga ,
A. Pelosio ,
A. Volpi ,
S. Vella ,
N. Legniti  and
A. De Felici
G. Rocchi
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
G. Ragona
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
C. Piga
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
A. Pelosio
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
A. Volpi
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
S. Vella
Affiliation:
Third Medical Clinic, University of Rome, 00161 Rome, Italy
N. Legniti
Affiliation:
Servizio di Sanità dell'esercito, Italy
A. De Felici
Affiliation:
Central Laboratory, ‘Lazzaro Spallanzani’ Hospital, Rome
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Immunization procedures with live attenuated and inactivated vaccines were carried out on a group of young recruits at the beginning of an outbreak of infection due to an A/Victoria/3/75-related virus strain, which occurred in February 1977 in a military camp. A retrospective investigation on protection from clinical influenza was then performed in order to investigate whether immunization with live virus vaccines, administered at the beginning of an epidemic, could provide early protection from the disease. In the course of the two weeks following vaccination, laboratory-confirmed clinical influenza cases occurred in 4 subjects among the 110 volunteers of the control group which received placebo, and in 8, 7 and 4 subjects respectively of the 3 groups of about 125 individuals, each of which received one of the following vaccine preparations: (a), live attenuated A/Victoria/3/75 influenza virus oral vaccine, grown on chick embryo kidney culture; (b), live attenuated nasal vaccine, a recombinant of A/Puerto Rico/8/34 with A/Victoria/3/75 virus; and (c), inactivated A/Victoria/3/75 virus intramuscular vaccine. These data do not support the hypothesis that, during an epidemic of infection, early protection from clinical influenza can be achieved through immunization with live attenuated or inactivated influenza virus vaccines, in spite of the high immunizing capability of the vaccine preparations.

Type
Research Article
Information
Journal of Hygiene , Volume 83 , Issue 3 , December 1979 , pp. 383 - 390
Copyright
Copyright © Cambridge University Press 1979

References

Alexandrova, G. I., Smorodintsev, A. A., Beljaeva, N. M., Vasil'ev, B., Geft, R. A., Panteleev, V. G., Seifer, M. A. & Selivanov, A. A. (1970). Testing the safety and effectiveness of oral administration of a live influenza vaccine. Bulletin of the World Health Organization 42, 429.Google Scholar
Alexeieva, A. K., Angiaparidze, O. G., Akopova, I. I., Porubel, L. A., Iakovleva, L. A., Alexandrova, A. H., Vasilieva, I. N., Ermakova, M. N., Sidorova, L. A., Rukavishnikova, G. E., Melnikova, S. K. & Graceva, E. N. (1978). Impiego dei virus dell'influenza coltivati nei tessuti nella produzione dei vaccini vivi dell'influenza. Symposium on live influenza vaccines, Florence, 5 November 1977. Giornale di malattie infettive e parassitarie (in press).Google Scholar
Alexieva, R. B., Petrova, S. M. & Jancheva, B. N. (1971). Studies on some biological properties of vaccinal influenza strains cultivated at low temperatures. Proc. Symposium on Live Influenza Vaccine. Yugoslav Academy of Sciences and Arts, Zagreb, 43–49.Google Scholar
Beare, A. S., Habershon, R. B., Tyrrel, D. A. J. & Hall, T. S. (1973). Recombinant live influenza vaccine virus-tests of transmissibility in man. Journal of Biological Standardization 1, 233.CrossRefGoogle Scholar
Crifò, S., Filiaci, F., Pelosio, A. & Rocchi, G. (1978). Risposta secretoria e sierica dopo vaccinazione antiinfluenzale per via nasale con virus vivo attenuato A/Victoria/3/75. Bollettino della Società Italiana di Biologia Sperimentale 54, 1021.Google Scholar
De Barbieri, A., Crovari, P., Cuneo-Crovari, P. & Giacometti, G. (1977). Further researches on live influenza virus vaccines. Developments in Biological Standardization 39, 73.Google ScholarPubMed
Donikian, M. A., Mckee, J. & Greene, L. C. (1977). Challenge versus natural infection as an index of protection after influenza immunization. Developments in Biological Standardization 39, 149.Google ScholarPubMed
Elveback, L. R., Fox, J. P., Ackerman, E., Langsworthy, A., Boyd, M. & Gatewood, L. (1976). An influenza simulation model for immunization studies. American Journal of Epidemiology 103, 152.Google Scholar
Ikić, D., Pasini, N., Hećimović, M., Juzbašić, M., Smerdel, S., Rajner, N. & Jelavić, V. (1977). Attenuation of influenza A/New Jersey/76 virus strain, preparation of live vaccine and vaccine reactogenicity in volunteers. Developments in Biological Standardization 39, 61.Google ScholarPubMed
Lobmann, M., Delem, A. & Jovanovic, D. (1977). Properties of A/Victoria/3/75 recombinants: developments of an attenuated strain RIT 4050. Developments in Biological Standardization 39, 43.Google Scholar
McDonald, J. C., Zuckerman, A. J., Beare, A. S. & Tyrrel, D. A. J. (1962). Trials of live influenza vaccine in the Royal Air Force. British Medical Journal i, 1036.Google Scholar
MacKenzie, J. S., MacKenzie, I., Lloyd, J. & Dent, V. (1975). Comparative trials of live attenuated and detergent split influenza virus vaccines. Journal of Hygiene 75, 425.CrossRefGoogle ScholarPubMed
Minor, T. E., Dick, E. C., Dick, R. C. & Inhorn, S. L. (1975). Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production and intrafamily transmission. Journal of Clinical Microbiology 2, 403.CrossRefGoogle Scholar
Murphy, B. R., Chalbub, E. G., Nusinoff, S. R. & Chanock, R. M. (1972). Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man. Journal of Infectious Diseases 126, 170.Google Scholar
Noble, G. R., Corey, L., Rosenberg, R. L., Hoke, K., Brown, W. J., Kaye, H. S., Bregman, D. J., Gregg, M. B. & Dowdle, W. R. (1975). An open field trial of live attenuated influenza A/England/42/72 (H3N2) vaccine. II. Illness and infection rates during an epidemic of A/Port Chalmers/-like influenza. 15th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington D.C. (abstract).Google Scholar
Prévost, J. M., Peetermans, J., Lamy, F. & Huygelen, C. (1973). Immune response to vaccination with a live influenza virus (H3N2) vaccine (‘Ann’ strain). Infection and Immunity 8, 420.CrossRefGoogle ScholarPubMed
Rocchi, G., Carlizza, L., Andreoni, M., Ragona, G., Piga, C., Pelosio, A., Volpi, A. & Muzzi, A. (1979). Protection from natural infection after live influenza virus immunization in an open population. Journal of Hygiene 82, 231.CrossRefGoogle Scholar
Rubin, R. G., Noble, G. R., Corey, L., Brown, W. J., Brandling-Bennett, D., Kaye, H. S., Coleman, M. T., Gregg, M. B. & Dowdle, W. R. (1976). Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial. Journal of Infectious Diseases 133, 603.CrossRefGoogle ScholarPubMed
Rytel, M. W., Jackson, L. J., Ferstenfeld, J. E. & Rosenkranz, M. A. (1975). New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity, immunogenicity, and protection efficacy. Journal of Infectious Diseases 132, 652.CrossRefGoogle ScholarPubMed
Sever, J. L. (1962). Application of a microtechnique to viral serological investigations. Journal of Immunology 88, 320.CrossRefGoogle ScholarPubMed
Shvetshova, E. G., Malusheva, A. M., Karapaz, N. M., Taros, L. U. & Smorodintsev, A. A. (1971). Epidemiological efficacy of live influenza vaccine and its use together with interferon inductors and amantadine. Proc. Symposium on Live Influenza Vaccine. Yugoslav Academy of Sciences and Arts, Zagreb143–155.Google Scholar
Shvetshova, E. G., Malusheva, A. M., Karapaz, N. M., Oleynikova, E. V., Vasiljeva, R. I., Gagarinova, V. M., Taros, L. U. & Smorodintsev, A. A. (1973). Epidemiological efficacy of live vaccine and other preparations against influenza. Transactions of the All-Union Research Institute of Influenza, Leningrad.Google Scholar